Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 699 37 057.4 |
96 | EP file number | EAKZ | 99 94 4294.0 |
86 | WO file number | WAKZ | PCT/EP99/05316 |
97 | EP publication number | EPN | 1100829 |
87 | WO publication number | WPN | 2000006604 |
54 | Designation/title | TI | VERWENDUNG VON BASILIXIMAB ZUR BEHANDLUNG VON RHEUMATOIDER ARTHRITIS UND HAUTERKRANKUNGEN |
51 | IPC main class | ICM (ICMV) | C07K 16/28 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 39/395 (2006.01) |
22 | DE application date | DAT | Jul 26, 1999 |
96 | EP application date | EAT | Jul 26, 1999 |
86 | WO application date | WAT | Jul 26, 1999 |
43 | Date of first publication | OT | Feb 10, 2000 |
| Date of publication of grant | PET | Sep 5, 2007 |
71/73 | Applicant/owner | INH | Novartis AG, 4056 Basel, CH; University College London, London, GB |
72 | Inventor | IN | AMLOT, Peter, Lloyd, London N8 9BL, GB; SCHREIER, Max, H., CH-4054 Basel, CH |
10 | Published DE documents | DEPN | Original document:
DE000069937057T2 Searchable text:
DE000069937057T2 |
| Address for service | | Novartis AG, 4056 BASEL, CH |
33 31 32
| Foreign priority | PRC PRNA PRDA
| GB 9816281 Jul 27, 1998
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| GB 9912460 May 27, 1999
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
87 | WO language of publication | WLANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE |
| Published EP/WO documents | EPWOPN | Original document:
EP000001100829 Searchable text:
EP000001100829 Original document:
EP000001100829B1 Searchable text:
EP000001100829B1 Original document:
WO002000006604 Searchable text:
WO002000006604 |
43 | Date of first publication | EVT | Feb 10, 2000 |
| Date of the first transfer into DPMAregister | EREGT | Sep 29, 2012 |
| Date of the (most recent) update in DPMAregister | REGT | Jan 5, 2025 (Show all update days)(Hide all update days)- Jan 5, 2025
- Procedures: New representative details, New representative details, 19.03.2014: changed
- Aug 21, 2019; Jul 30, 2019; Oct 19, 2018; Jul 27, 2018; Aug 2, 2017; Jul 28, 2016; Aug 25, 2015; Aug 1, 2015; Aug 11, 2014; Aug 4, 2014; Mar 20, 2014; Aug 9, 2013; Jan 23, 2013
- Historical data not available for this/these date(s)
- Sep 29, 2012
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 5)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Aug 7, 2007 |
71/73 | Applicant/owner | INH | Novartis AG, 4056 Basel, CH; University College London, London, GB |
71/73 | Previous applicant/owner | INHF | Novartis AG, 4056 Basel, CH, Novartis-Erfindungen Verwaltungsgesellschaft m.b.H., Wien, AT, University College London, London, GB |